AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

8,253.00p
   
  • Change Today:
    -39.00p
  • 52 Week High: 8,812.00
  • 52 Week Low: 6,794.00
  • Currency: UK Pounds
  • Shares Issued: 1,549.12m
  • Volume: 2,872,425
  • Market Cap: £127,849m
  • RiskGrade: 123

Wednesday broker round-up

By Caoimhe Toman

Date: Wednesday 16 Jun 2021

LONDON (ShareCast) - (Sharecast News) - Pets At Home: Berenberg reiterates buy with a target price of 540p.



Sirius Real Estate: Berenberg reiterates buy with a target price of 110p.

IG Design Group: Canaccord reiterates buy with a target price of 790p.

Bellway: Canaccord reiterates buy with a target price of 4,060p.

Glaxosmithkline: Liberum reiterates buy with a target price of 1,700p.

Bellway: Liberum reiterates buy with a target price of 4,200p.

Astrazeneca: Deutsche Bank reiterates buy with a target price of 10,200p.

Unilever: Deutsche Bank reiterates buy with a target price of 5,500p.

Barclays: JP Morgan reiterates overweight with a target price of 230p.

Clarkson: JP Morgan reiterates overweight with a target price of 4,110p.

SSP Group: Credit Suisse reiterates underperfom with a target price of 210p.

Admiral Group: Credit Suisse reiterates underperfom with a target price of 2,300p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 8,253.00p
Change Today -39.00p
% Change -0.47 %
52 Week High 8,812.00
52 Week Low 6,794.00
Volume 2,872,425
Shares Issued 1,549.12m
Market Cap £127,849m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
84.41% below the market average84.41% below the market average84.41% below the market average84.41% below the market average84.41% below the market average
7.69% below the sector average7.69% below the sector average7.69% below the sector average7.69% below the sector average7.69% below the sector average
Price Trend
19.69% below the market average19.69% below the market average19.69% below the market average19.69% below the market average19.69% below the market average
1.64% below the sector average1.64% below the sector average1.64% below the sector average1.64% below the sector average1.64% below the sector average
Income
30.26% below the market average30.26% below the market average30.26% below the market average30.26% below the market average30.26% below the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Growth
88.36% above the market average88.36% above the market average88.36% above the market average88.36% above the market average88.36% above the market average
82.86% above the sector average82.86% above the sector average82.86% above the sector average82.86% above the sector average82.86% above the sector average

What The Brokers Say

Strong Buy 21
Buy 2
Neutral 3
Sell 0
Strong Sell 1
Total 27
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 25-Feb-21 13-Aug-20
Paid 29-Mar-21 14-Sep-20
Amount 190.00¢ 90.00¢

Trades for 27-Jul-2021

Time Volume / Share Price
16:16 20,556 @ 8,246.70p
16:36 5,504 @ 8,263.44p
16:36 18,711 @ 8,257.13p
16:36 5,000 @ 8,253.00p
16:36 5,000 @ 8,253.00p

Top of Page